Enantioselective pharmacokinetics of tramadol and its three main metabolites; impact of CYP2D6 , CYP2B6 , and CYP3A4 genotype-Reference-Cited by-同舟云学术

Enantioselective pharmacokinetics of tramadol and its three main metabolites; impact of CYP2D6 , CYP2B6 , and CYP3A4 genotype

Author:

Haage Pernilla¹²^ORCID,Kronstrand Robert¹²,Josefsson Martin¹³,Calistri Simona⁴⁵,van Schaik Ron H. N.⁴,Green Henrik¹²,Kugelberg Fredrik C.¹²

Affiliation:

1. Department of Forensic Genetics and Forensic Toxicology; National Board of Forensic Medicine; Linköping Sweden

2. Department of Medical and Health Sciences; Division of Drug Research; Linköping University; Linköping Sweden

3. Department of Physics, Chemistry and Biology; Linköping University; Linköping Sweden

4. Department of Clinical Chemistry; Erasmus University Medical Center; Rotterdam The Netherlands

5. Scuola di Scienze della Salute Umana; Università degli studi di Firenze; Florence Italy

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

Reference31 articles.

2. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol;Raffa;J Pharmacol Exp Ther,1993

4. The pharmacogenetics of tramadol;Lassen;Clin Pharmacokinet,2015

5. Tramadol: seizures, serotonin syndrome, and coadministered antidepressants;Sansone;Psychiatry (Edgmont),2009

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene polymorphism impact on opioid analgesic usage;Journal of Advanced Pharmaceutical Technology & Research;2024-07